Characterization and Structural Impact of Five Novel PROS1 Mutations in Eleven Protein S-deficient Families

Summary

Heterozygozity for four novel missense mutations (W108C, W342R, E349K and L485S) and one novel 4 bp deletion (ACdelAAAG affecting codons 632-633) was identified in PROS1 of unrelated thrombosis prone Danish families with protein S type I or III deficiency. The 4 bp deletion results in a frameshift leading to replacement of the coding sequence for the 3 C-terminal amino acids by an abnormal extended sequence that codes for 9 amino acids. The E349K substitution was found in 7 families. Haplotype analysis using 7 microsatellite markers flanking PROS1 was consistent with a common founder for this mutation. The mutations reported here are most likely the cause of the protein S deficiency. Firstly, the four missense mutations cosegre-gate with the abnormal plasma protein S phenotype and lead to the loss of highly conserved amino acids. Secondly, computer analysis of structural models of protein S predicts that the substitutions could affect proper protein folding and/or stability. Analysis of platelet mRNA from subjects with the W108C, E349K, L485S mutation or the 4 bp deletion showed that mutated mRNA was expressed in significant amounts suggesting that mutated molecules are synthesized. Our results are compatible with defective protein folding/unstable molecules, impaired secretion and intracellular degradation of mutated protein, which appear to be the major molecular disease mechanisms for missense mutations and certain other mutations found in genetic disorders.

Keywords

Protein S mutations - venous thromboembolism - founder effect - structural analysis

• References

• 1 Dahlbäck B. Protein S and C4b-binding protein: Components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 1991; 66: 49-61.
• 2 Dahlbäck B. The protein C anticoagulant system: Inherited defects as basis for venous thrombosis. Thromb Res 1995; 77: 1-43.
• 3 Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
• 4 Heeb MJ, Rosing J, Bakker HM, Fernandez JA, Tans G, Griffin JH. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 1994; 91: 2728-32.
• 5 Hackeng TM, Van’t Veer C, Meijers JCM, Bouma BN. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem 1994; 269: 21051-8.
• 6 Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN. Inhibition of the intrinsic factor X activating complex by protein S: Evidence for a specific binding of protein S to factor VIII. Blood 1995; 86: 1062-71.
• 7 De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-44.
• 8 Makris M, Leach M, Beauchamp NJ, Daly ME, Cooper PC, Hampton KK, Bayliss P, Peake IR, Miller GJ, Preston FE. Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S. Blood 2000; 95: 1935-41.
• 9 Gandrille S, Borgel D, Sala N, Espinosa-Parrilla Y, Simmonds R, Rezende S, Lind B, Mannhalter C, Pabinger I, Reitsma PH, Formstone C, Cooper DN, Saito H, Suzuki K, Bernardi E, Aiach M. Protein S deficiency: A database of mutations – summary of the first update. Thromb Haemost 2000; 84: 918-9.
• 10 Marchetti G, Legnani C, Patracchini P, Gemmati D, Ferrati M, Palareti G, Coccheri S, Bernardi F. Study of a protein S gene polymorphism at DNA and mRNA level in a family with symptomatic protein S deficiency. Br J Haematol 1993; 85: 173-5.
• 11 Schmidel DK, Tatro AV, Phelps LG, Tomczak JA, Long GL. Organization of the human protein S genes. Biochemistry 1990; 29: 7845-52.
• 12 Ploos van Amstel HK, Reitsma PH, Van der Logt CPE, Bertina RM. Intronexon organization of the active human protein S gene PS and its pseudo-gene PS : Duplication and silencing during primate evolution. Biochemistry 1990; 29: 7853-61.
• 13 Edenbrandt C-M, Lundwall Å, Wydro R, Stenflo J. Molecular analysis of the gene for vitamin K dependent protein S and its pseudogene. Cloning and partial gene organization. Biochemistry 1990; 29: 7861-8.
• 14 He X, Shen L, Villoutreix BO, Dahlback B. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem 1998; 273: 27449-58.
• 15 Dahlbäck B, Hildebrand B, Malm J. Characterization of functionally important domains in human vitamin K-dependent protein S using monoclonal antibodies. J Biol Chem 1990; 265: 8127-35.
• 16 Stenberg Y, Drakenberg T, Dahlbäck B, Stenflo J. Characterization of recombinant epidermal growth factor (EGF) – like modules from vitamin-K-dependent protein S expressed in Spodoptera cells – The cofactor activity depends on the N-terminal EGF module in human protein S. Eur J Biochem 1998; 251: 558-64.
• 17 Van Wijnen M, Stam JG, Chang GTG, Meijers JCM, Reitsma PH, Bertina RM, Bouma BN. Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain. Biochem J 1998; 330: 389-96.
• 18 Joseph DR, Baker ME. Sex hormone-binding globulin, androgen-binding protein, and vitamin K-dependent protein S are homologous to laminin A, merosin, and Drosophila crumbs protein. FASEB J 1992; 6: 2477-81.
• 19 Villoutreix BO, De Frutos PG, Lövenklev M, Linse S, Fernlund P, Dahl-bäck B. SHBG region of the anticoagulant cofactor protein S: Secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins 1997; 29: 478-91.
• 20 Evenäs P, De Frutos PG, Linse S, Dahlbäck B. Both G-type domains of protein S are required for the high-affinity interaction with C4b-binding protein. Eur J Biochem 1999; 266: 935-42.
• 21 Evenas P, Garcia dF, Nicolaes GA, Dahlbäck B. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa. Thromb Haemost 2000; 84: 271-7.
• 22 Pugliese L, Arruda VR, Annichino-Bizzacchi JM. A novel nonsense mutation 6,E-X in the protein S gene causes type I deficiency. Hum Hered 1999; 49: 121-2.
• 23 Hermida J, Faioni EM, Mannucci PM. Poor relationship between pheno-types of protein S deficiency and mutations in the protein S alpha gene. Thromb Haemost 1999; 82: 1634-8.
• 24 Andersen BD, Lind B, Philips M, Hansen AB, Ingerslev J, Thorsen S. Two mutations in exon XII of the protein S gene in four thrombophilic families resulting in prematur stop codons and depressed levels of mutated mRNA. Thromb Haemost 1996; 76: 143-50.
• 25 Andersen BD, Bisgaard ML, Mustafa S, Mannhalter C. Founder effect in protein S-deficient families sharing a hot spot mutation in PROS1 [letter]. Blood 1999; 93: 759.
• 26 Lind B, Van Solinge WW, Schwartz M, Thorsen S. Splice site mutation in the human protein C gene associated with venous thrombosis: Demonstration of exon skipping by ectopic transcript analysis. Blood 1993; 82: 2423-32.
• 27 Diepstraten CM, Ploos van Amstel JK, Reitsma PH, Bertina RM. A CCA/CCG neutral dimorphism in the codon for Pro 626 of the human protein S gene PSα (PROS1). Nucleic Acids Res 1991; 19: 5091-9.
• 28 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-3703.
• 29 Villoutreix BO, Teleman O, Dahlback B. A theoretical model for the Gla-TSR-EGF-1 region of the anticoagulant cofactor protein S: from bio-structural pathology to species-specific cofactor activity. J Comput Aided Mol Des 1997; 11: 293-304.
• 30 Villoutreix BO, Dahlbäck B, Borgel D, Gandrille S, Muller YA. Three-dimensional model of the SHBG-like region of anticoagulant protein S: New structure-function insights. Proteins 2001; 43: 203-16.
• 31 Zöller B, Berntsdotter A, García de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 1995; 85: 3518-23.
• 32 Koeleman BPC, Van Rumpt D, Hamulyák K, Reitsma PH, Bertina RM. Factor V Leiden: An additional risk factor for thrombosis in protein S deficient families. Thromb Haemost 1995; 74: 580-3.
• 33 Beauchamp NJ, Daly ME, Cooper PC, Makris M, Preston FE, Peake IR. Molecular basis of protein S deficiency in three families also showing independent inheritance of factor V Leiden. Blood 1996; 88: 1700-7.
• 34 Makris M, Preston FE, Beauchamp NJ, Cooper PC, Daly ME, Hampton KK, Bayliss P, Peake IR, Miller GJ. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia. Thromb Haemost 1997; 78: 1426-9.
• 35 Tisi D, Talts JF, Timpl R, Hohenester E. Structure of the C-terminal laminin G-like domain pair of the laminin alpha2 chain harbouring binding sites for alpha-dystroglycan and heparin. EMBO J 2000; 19: 1432-40.
• 36 Beauchamp NJ, Daly ME, Makris M, Preston FE, Peake IR. A novel mutation in intron K of the PROS1 gene causes aberrant RNA splicing and is a common cause of protein S deficiency in a UK thrombophilia cohort. Thromb Haemost 1998; 79: 1086-91.
• 37 Borgel D, Duchemin J, Alhenc-Gelas M, Matheron C, Aiach M, Gandrille S. Molecular basis for protein S hereditary deficiency: Genetic defects observed in 118 patients with type I and type IIa deficiencies. J Lab Clin Med 1996; 128: 218-27.
• 38 Mustafa S, Pabinger I, Mannhalter C. Protein S deficiency type I: Identification of point mutations in 9 of 10 families. Blood 1995; 86: 3444-51.
• 39 Formstone CJ, Wacey AI, Berg LP, Rahman S, Bevan D, Rowley M, Voke J, Bernardi F, Legnani C, Simioni P, Girolami A, Tuddenham EGD, Kakkar VV, Cooper DN. Detection and characterization of seven novel protein S (PROS) gene lesions: Evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. Blood 1995; 86: 2632-41.
• 40 Yamazaki T, Katsumi A, Okamoto Y, Takafuta T, Tsuzuki S, Kagami K, Sugiura I, Kojima T, Fujimura K, Saito H. Two distinct novel splice site mutations in a compound heterozygous patient with protein S deficiency. Thromb Haemost 1997; 77: 14-20.
• 41 Bross P, Corydon TJ, Andresen BS, Jørgensen MM, Bolund L, Gregersen N. Protein misfolding and degradation in genetic diseases. Hum Mutat 1999; 14: 186-98.
• 42 Wickner S, Maurizi MR, Gottesman S. Posttranslational quality control: Folding, refolding and degrading proteins. Science 1999; 286: 1888-93.
• 43 Yamazaki T, Katsumi A, Kagami K, Okamoto Y, Sugiura I, Hamaguchi M, Kojima T, Takamatsu J, Saito H. Molecular basis of a hereditary type I protein S deficiency caused by a substitution of Cys for Arg474. Blood 1996; 87: 4643-50.
• 44 Espinosa-Parrilla Y, Yamazaki T, Sala N, Dahlbäck B, De Frutos PG. Protein S secretion differences of missense mutants account for phenotypic heterogeneity. Blood 2000; 95: 173-9.
• 45 Giri TK, De Frutos PG, Yamazaki T, Villoutreix BO, Dahlback B. In vitro characterisation of two naturally occurring mutations in the thrombin-sensitive region of anticoagulant protein S. Thromb Haemost 1999; 82: 1627-33.
• 46 Katsumi A, Senda T, Yamashita Y, Yamazaki T, Hamaguchi R, Kojima T, Kobayashi S, Saito H. Protein C Nagoya, an elongated mutant of protein C, is retained within the endoplasmic reticulum and is associated with GRP78 and GRP94. Blood 1996; 87: 4164-75.
• 47 Katsumi A, Kojima T, Senda T, Yamazaki T, Tsukamoto H, Sugiura I, Kobayashi S, Miyata T, Umeyama H, Saito H. The carboxyl-terminal region of protein C is essential for its secretion. Blood 1998; 91: 3784-91.